From the ∗Department of Radiology, Swiss Paraplegic Centre, Nottwil

†Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland

‡Max Planck Institute for Biological Cybernetics, Tuebingen, Germany

§Department of Diagnostic, Interventional, and Pediatric Radiology, University Hospital of Bern, Inselspital, University of Bern, Bern

∥Clinical Trial Unit, Swiss Paraplegic Centre, Nottwil

¶Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich

#Support Center for Advanced Neuroimaging, Neuroradiology, University Hospital Inselspital, Bern

∗∗Department of Paraplegia, Rehabilitation, and Quality Management, Swiss Paraplegic Centre, Nottwil, Switzerland

††Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX.

Received for publication May 3, 2022; and accepted for publication, after revision, June 18, 2022.

Conflicts of interest and sources of funding: This study was funded by the Swiss Paraplegic Foundation (Research Program Radiology), Swiss National Science Foundation (grant number 143715), Hartmann-Müller-Stiftung (grant number 2047), and ERC Starting Grant (SYNAPLAST MR, grant number 679927).

Correspondence to: Patrik O. Wyss, PhD, Department of Radiology, Swiss Paraplegic Centre, Guido A. Zaech Strasse 1, CH-6207, Nottwil, Switzerland. E-mail: [email protected].

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).